EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pharnext's enterprise value is €26.26 Mil.
Pharnext's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01 Mil. Therefore, Pharnext's EV-to-Revenue for today is 2,626.20.
The historical rank and industry rank for Pharnext's EV-to-Revenue or its related term are showing as below:
XPAR:ALPHA'
s EV-to-Revenue Range Over the Past 10 Years
Min: 343.96 Med: 407526.86 Max: 29146480.86
Current: 2626.2
During the past 12 years, the highest EV-to-Revenue of Pharnext was 29146480.86. The lowest was 343.96. And the median was 407526.86.
XPAR:ALPHA's EV-to-Revenue is ranked worse than 97.41% of 1043
companies
in the Biotechnology industry
Industry Median: 8.21
vs XPAR:ALPHA: 2626.20
As of today (2024-05-21), Pharnext's stock price is €0.0561.
Pharnext's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €36.72. Therefore, Pharnext's PS Ratio for today is 0.00.
Pharnext EV-to-Revenue Historical Data
The historical data trend for Pharnext's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pharnext's EV-to-Revenue
For the Biotechnology subindustry, Pharnext's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharnext's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pharnext's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pharnext's EV-to-Revenue falls into.
Pharnext's current Enterprise Value is €26.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pharnext's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharnext's share price for today is €0.0561.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €36.72.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharnext EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pharnext's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:ALPHA has been successfully added to your 